Compare INVA & BCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVA | BCAT |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2004 | N/A |
| Metric | INVA | BCAT |
|---|---|---|
| Price | $19.94 | $14.33 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $36.60 | N/A |
| AVG Volume (30 Days) | ★ 789.4K | 308.8K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.38% |
| EPS Growth | ★ 53.96 | N/A |
| EPS | ★ 1.52 | 1.43 |
| Revenue | ★ $388,521,000.00 | N/A |
| Revenue This Year | $13.23 | N/A |
| Revenue Next Year | $8.62 | N/A |
| P/E Ratio | $13.53 | ★ $11.41 |
| Revenue Growth | ★ 10.14 | N/A |
| 52 Week Low | $16.52 | $13.67 |
| 52 Week High | $22.76 | $16.38 |
| Indicator | INVA | BCAT |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 45.53 |
| Support Level | $20.44 | $14.41 |
| Resistance Level | $21.00 | $14.57 |
| Average True Range (ATR) | 0.57 | 0.12 |
| MACD | -0.22 | 0.01 |
| Stochastic Oscillator | 2.70 | 42.54 |
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.